SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000899140-07-000247
Filing Date
2007-02-13
Accepted
2007-02-13 17:23:08
Documents
2
Group Members
DANIEL S. LOEB

Document Format Files

Seq Description Document Type Size
1 FIRST AMENDMENT t3603659b.txt SC 13G/A 10955
3 POA t3603659c.txt EX-99.1 4730
  Complete submission text file 0000899140-07-000247.txt   17857
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Subject) CIK: 0000887023 (see all company filings)

IRS No.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44359 | Film No.: 07611689
SIC: 2834 Pharmaceutical Preparations

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A